Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

Published:2008-04-03 Issue:9 Volume:23 Page:2750-2760
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Ko G. J.,Kang Y. S.,Han S. Y.,Lee M. H.,Song H. K.,Han K. H.,Kim H. K.,Han J. Y.,Cha D. R.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/23/9/2750/7630672/gfn157.pdf

Reference35 articles.

1. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy

2. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.

3. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-β

4. Increased expression of selectins in kidneys of patients with diabetic nephropathy

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nephroprotective effect of pioglitazone in a Wistar rat model of adenine‑induced chronic kidney disease;Experimental and Therapeutic Medicine;2024-08-07

2. Mesoporous silica and alumina nanoparticles to improve drug delivery of pioglitazone on diabetic type 1 nephropathy in rats;Research in Pharmaceutical Sciences;2024-07

3. Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease;International Journal of Molecular Sciences;2024-04-15

4. A randomized controlled pilot trial of anakinra and pioglitazone for protein metabolism in patients on maintenance haemodialysis;Journal of Cachexia, Sarcopenia and Muscle;2024-01-04

5. A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review;Current Diabetes Reviews;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3